Clinical outcomes of high on-treatment platelet reactivity in Koreans receiving elective percutaneous coronary intervention (from results of the CROSS VERIFY study)

American Journal of Cardiology

Volumn 108, Issue 11, 2011, Pages 1556-1563

  Park, Kyung Woo ^a   Jeon, Ki Hyun ^a   Kang, Si Hyuk ^a   Oh, Il Young ^a   Cho, Hyun Jai ^a   Lee, Hae Young ^a   Kang, Hyun Jae ^a   Park, Sue K ^b   Koo, Bon Kwon ^a   Oh, Byung Hee ^a   Park, Young Bae ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DETERMINATION; DRUG RESPONSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ON TREATMENT PLATELET REACTIVITY; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80955144204     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.012     Document Type: Article

References (29)

1. A.I. Schafer Genetic and acquired determinants of individual variability of response to antiplatelet drugs Circulation 108 2003 910 911
2. D.J. Angiolillo Variability in responsiveness to oral antiplatelet therapy Am J Cardiol 103 suppl 2009 27A 34A
3. Park KW, Park JJ, Jeon KH, Kang SH, Oh IY, Yang HM, Cho HJ, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS. Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans. Cardiovasc Ther. In press.
4. K.W. Park, J.J. Park, K.H. Jeon, S.H. Kang, I.Y. Oh, H.M. Yang, H.J. Cho, H.Y. Lee, H.J. Kang, B.K. Koo, B.H. Oh, Y.B. Park, and H.S. Kim Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status Arterioscler Thromb Vasc Biol 31 2011 665 671
5. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, J.T. Brandt, J.R. Walker, E.M. Antman, W. Macias, E. Braunwald, and M.S. Sabatine Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
6. A.R. Shuldiner, J.R. O'Connell, K.P. Bliden, A. Gandhi, K. Ryan, R.B. Horenstein, C.M. Damcott, R. Pakyz, U.S. Tantry, Q. Gibson, T.I. Pollin, W. Post, A. Parsa, B.D. Mitchell, N. Faraday, W. Herzog, and P.A. Gurbel Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
7. M.J. Price, K.R. Nayak, C.M. Barker, D.E. Kandzari, and P.S. Teirstein Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
8. J.W. Suh, B.K. Koo, S.Y. Zhang, K.W. Park, J.Y. Cho, I.J. Jang, D.S. Lee, D.W. Sohn, M.M. Lee, and H.S. Kim Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel CMAJ 174 2006 1715 1722
9. J.M. Lee, S. Park, D.J. Shin, D. Choi, C.Y. Shim, Y.G. Ko, J.S. Kim, E.S. Shin, C.W. Chang, J.E. Lee, and Y. Jang Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans Am J Cardiol 104 2009 46 51
10. M.J. Price, S. Endemann, R.R. Gollapudi, R. Valencia, C.T. Stinis, J.P. Levisay, A. Ernst, N.S. Sawhney, R.A. Schatz, and P.S. Teirstein Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
11. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Platelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
12. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, C. Giglioli, P. Buonamici, D. Antoniucci, R. Abbate, and G.F. Gensini Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
13. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
14. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, M. Galvani, H.A. Katus, L.K. Newby, J. Ravkilde, B. Chaitman, P.M. Clemmensen, M. Dellborg, H. Hod, P. Porela, R. Underwood, J.J. Bax, G.A. Beller, R. Bonow, E.E. Van der Wall, J.P. Bassand, W. Wijns, T.B. Ferguson, P.G. Steg, B.F. Uretsky, D.O. Williams, P.W. Armstrong, E.M. Antman, K.A. Fox, C.W. Hamm, E.M. Ohman, M.L. Simoons, P.A. Poole-Wilson, E.P. Gurfinkel, J.L. Lopez-Sendon, P. Pais, S. Mendis, J.R. Zhu, L.C. Wallentin, F. Fernández-Avilés, K.M. Fox, A.N. Parkhomenko, S.G. Priori, M. Tendera, L.M. Voipio-Pulkki, A. Vahanian, A.J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, J. Morais, S. Brener, R. Harrington, D. Morrow, M. Lim, M.A. Martinez-Rios, S. Steinhubl, G.N. Levine, W.B. Gibler, D. Goff, M. Tubaro, D. Dudek, N. Al-Attar Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Circulation 116 2007 2634 2653
16. D.L. Bhatt, and E.J. Topol Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes Circulation 112 2005 906 915
17. D.E. Cutlip, and R.E. Kuntz Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes Circulation 112 2005 916 923
18. W.E. Boden, R.A. O'Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, W.J. Kostuk, M. Knudtson, M. Dada, P. Casperson, C.L. Harris, B.R. Chaitman, L. Shaw, G. Gosselin, S. Nawaz, L.M. Title, G. Gau, A.S. Blaustein, D.C. Booth, E.R. Bates, J.A. Spertus, D.S. Berman, G.B. Mancini, W.S. Weintraub COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
19. D.E. Cutlip, D.S. Baim, K.K. Ho, J.J. Popma, A.J. Lansky, D.J. Cohen, J.P. Carrozza Jr, M.S. Chauhan, O. Rodriguez, and R.E. Kuntz Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
20. L. Mauri, W.-h. Hsieh, J.M. Massaro, K.K.L. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
21. D.W. Park, S.W. Park, K.H. Park, B.K. Lee, Y.H. Kim, C.W. Lee, M.K. Hong, J.J. Kim, and S.J. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
22. D.W. Park, S.W. Park, S.W. Lee, Y.H. Kim, C.W. Lee, M.K. Hong, J.J. Kim, and S.J. Park Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents Am J Cardiol 99 2007 774 778
23. T. Kimura, T. Morimoto, Y. Nakagawa, T. Tamura, K. Kadota, H. Yasumoto, H. Nishikawa, Y. Hiasa, T. Muramatsu, T. Meguro, N. Inoue, H. Honda, Y. Hayashi, S. Miyazaki, S. Oshima, T. Honda, N. Shiode, M. Namura, T. Sone, M. Nobuyoshi, T. Kita, K. Mitsudo J-Cypher Registry Investigators Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
24. Z. Desta, X. Zhao, J.G. Shin, and D.A. Flockhart Clinical significance of the cytochrome P450 2C19 genetic polymorphism Clin Pharmacokinet 41 2002 913 958
25. M.A. Kall, and J. Clausen Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man Hum Exp Toxicol 14 1995 801 807
26. K. Lee, S.W. Lee, J.W. Lee, S.Y. Kim, Y.J. Youn, M.S. Ahn, J.Y. Kim, B.S. Yoo, J. Yoon, and K.H. Choe The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the VerifyNow P2Y12 assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation Korean Circ J 39 2009 512 518
27. M. Lordkipanidze, C. Pharand, T.A. Nguyen, E. Schampaert, and J.G. Diodati Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition Ther Drug Monit 30 2008 372 378
28. L. Gruberg, N.J. Weissman, R. Waksman, S. Fuchs, R. Deible, E.E. Pinnow, L.M. Ahmed, K.M. Kent, A.D. Pichard, W.O. Suddath, L.F. Satler, and J. Lindsay Jr The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39 2002 578 584
29. G. Sarno, L. Rber, Y. Onuma, S. Garg, S. Brugaletta, R.T. van Domburg, T. Pilgrim, N. Pfffli, P. Wenaweser, S. Windecker, and P. Serruys Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents Am J Cardiol 108 2011 195 201